Abclon Inc
174900
Company Profile
Business description
Abclon Inc is engaged in the research and development of antibody drugs. Its business sector is divided into Antibody drug and Bio CRO.
Contact
1403, Ace Twin Tower 1
212-1, Guro-dong
Guro-gu
Seoul152-779
KORT: +82 221091294
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
60
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,633.80 | 4.00 | -0.05% |
| CAC 40 | 7,779.72 | 8.38 | -0.11% |
| DAX 40 | 23,933.23 | 104.96 | -0.44% |
| Dow JONES (US) | 42,215.73 | 117.03 | 0.28% |
| FTSE 100 | 8,716.45 | 9.56 | -0.11% |
| HKSE | 23,247.47 | 325.91 | -1.38% |
| NASDAQ | 19,175.87 | 74.93 | 0.39% |
| Nikkei 225 | 37,890.86 | 542.12 | -1.41% |
| NZX 50 Index | 12,354.98 | 73.67 | 0.60% |
| S&P 500 | 5,912.17 | 23.62 | 0.40% |
| S&P/ASX 200 | 8,409.00 | 0.80 | -0.01% |
| SSE Composite Index | 3,351.63 | 11.81 | -0.35% |